Chapel Hill, NC, United States of America

Timothy Anh-Hieu Dinh

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Timothy Anh-Hieu Dinh

Introduction

Timothy Anh-Hieu Dinh is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medical research, particularly in the study of human fibrolamellar hepatocellular carcinoma (FL-HCC). His work has implications for both diagnosis and treatment of this rare form of cancer.

Latest Patents

Dinh holds a patent for a model of human fibrolamellar hepatocellular carcinoma cells, which are maintained as a transplantable tumor line in a host. The patent outlines methods for establishing a transplantable human FL-HCC tumor line, as well as ex vivo cultures of the FL-HCC. Additionally, it provides methods for diagnosing and treating FL-HCC tumors. This patent represents a significant advancement in cancer research and treatment.

Career Highlights

Timothy Dinh is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving patient outcomes. With a focus on innovative solutions, Dinh continues to contribute to the understanding of complex medical conditions.

Collaborations

Dinh collaborates with esteemed colleagues such as Eliane Wauthier and Tsunekazu Oikawa. These partnerships enhance the research efforts and foster a collaborative environment for innovation.

Conclusion

Timothy Anh-Hieu Dinh's contributions to the field of medical research, particularly through his patent on human fibrolamellar hepatocellular carcinoma, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…